Druglogic
DrugLogic, founded in 2006, specializes in pharmacovigilance, epidemiology, and drug safety surveillance, primarily serving pharmaceutical and biotechnical companies.
Profile
DrugLogic provides data analytics and workflow management tools for pharmacovigilance and drug safety surveillance.
DrugLogic, founded in 2006, specializes in pharmacovigilance, epidemiology, and drug safety surveillance, primarily serving pharmaceutical and biotechnical companies. The company’s flagship product, Qscan®-ERM, is a flexible workflow management and analysis tool designed to monitor both proprietary adverse event data and publicly available data sources. DrugLogic has expanded its offerings to include Qscan®-MAUDE for medical device manufacturers and Qscan-Medical for managing large databases like claims and EMR.
The company has developed Personalized Medical Analytics (PMA) solutions, including Safe-Rx™, Manage-RX™, and PMA-DS, aimed at precision decision support for healthcare providers. DrugLogic has demonstrated a commitment to innovation, integrating with Google’s geospatial mapping and releasing a white-label platform. The company is set to participate in key industry events in 2025, including the 41st ISPE Annual Meeting and Pharmacovigilance World 2025. Despite its advancements, DrugLogic faces challenges in maintaining relevance in a rapidly evolving market and ensuring the scalability of its solutions.
Who buys this
- Pharmaceutical companies
- Biotechnical companies
- Medical device manufacturers
- Managed care organizations
- Healthcare providers
Strengths and what to watch
Strengths
- Proprietary Qscan®-ERM for adverse event monitoring
- Integration with Google’s geospatial mapping
- Personalized Medical Analytics (PMA) solutions
Watch for
- Challenges in maintaining market relevance
- Scalability of solutions for large databases
- Dependence on proprietary data sources
Key Information
- Founded
- 2006
Frequently Asked Questions
What does DrugLogic do?
DrugLogic provides data analytics and workflow management tools for pharmacovigilance and drug safety surveillance, helping pharmaceutical, biotechnical, and medical device companies monitor adverse events and manage large databases like claims and EMR.
What is Qscan®-ERM?
Qscan®-ERM is DrugLogic’s flagship workflow management and analysis tool designed to monitor proprietary adverse event data and public sources, offering flexible solutions for pharmacovigilance and drug safety surveillance.
What are DrugLogic’s Personalized Medical Analytics solutions?
DrugLogic’s Personalized Medical Analytics (PMA) solutions, including Safe-Rx™, Manage-RX™, and PMA-DS, provide precision decision support for healthcare providers by analyzing adverse events and managing large datasets like claims and EMR.
How does DrugLogic integrate with Google’s geospatial mapping?
DrugLogic integrates Google’s geospatial mapping into its analytics tools to enhance pharmacovigilance and drug safety surveillance, enabling more precise monitoring and analysis of adverse events across geographic regions.
Who are DrugLogic’s primary customers?
DrugLogic primarily serves pharmaceutical companies, biotechnical firms, medical device manufacturers, managed care organizations, and healthcare providers, offering tailored solutions for drug safety and pharmacovigilance.
What challenges does DrugLogic face?
DrugLogic faces challenges in maintaining market relevance, ensuring the scalability of its solutions for large databases, and managing dependence on proprietary data sources in a rapidly evolving pharmacovigilance landscape.
Sources
- www.druglogic.com — DrugLogic released a white-label platform in 2019
- www.druglogic.com — DrugLogic demonstrated EMR/EHR analytics in 2018
- www.druglogic.com — DrugLogic integrated with Google’s geospatial mapping in 2018
- www.druglogic.com — DrugLogic is participating in the 41st ISPE Annual Meeting in 2025